[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease
{{output}}
Objective: Lactacystin has been used to establish rodent models of Parkinson disease (PD), with cerebral α-synuclein inclusions. This study evaluated the uptake of [18F]9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]FP-(+)-DTBZ),... ...
